Status:

RECRUITING

Single vs. Dual Implant Fixation for Distal Femur Fractures in Older or Compromised Adults

Lead Sponsor:

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Collaborating Sponsors:

Orthopaedic Trauma Association

Conditions:

Distal Femur Fractures

Eligibility:

All Genders

18-100 years

Phase:

NA

Brief Summary

The goal of this clinical trial is to assess the feasibility of conducting a larger study comparing single implant fixation (SIF) and dual implant fixation (DIF) for treating distal femur fractures (D...

Detailed Description

The Investigators aim to conduct a multi-centre, preliminary RCT to determine the feasibility and inform the design of a definitive trial comparing patient-important outcomes between patients aged 40 ...

Eligibility Criteria

Inclusion

  • Isolated DFF (native AO/OTA-type A2, A3, C or periprosthetic Lewis and
  • Rorabeck type 1, 2) and either:
  • Age ≥ 60 years or;
  • Age 18-60 years with one or more of:
  • i. Osteoporosis ii. Obesity (Body Mass Index \>30) iii. Metaphyseal comminution iv. Diabetes
  • Fracture amenable to plating and nailing
  • Ability to read and speak English or availability of a translator
  • Acute fractures (within 14-days of injury)
  • No surgeon preference regarding SIF vs. DIF
  • Provision of informed consent

Exclusion

  • Candidate for primary or revision arthroplasty (surgeon opinion)
  • Periprosthetic fracture with loose implant
  • Gustillo grade III open fractures
  • Ipsilateral hip implant
  • Likely problems, in the judgment of the investigators, with maintaining follow-up (i.e., no fixed address, mentally competent to give consent, etc.)
  • Non-ambulatory patients
  • Multi-trauma patient (Injury Severity Score ≥ 16)
  • Lack of bone substance or poor bone-quality which, in the surgeon's judgment, makes fixation impossible
  • Any concomitant lower-extremity injury
  • Inability to obtain informed consent due to language barrier

Key Trial Info

Start Date :

September 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2030

Estimated Enrollment :

44 Patients enrolled

Trial Details

Trial ID

NCT06944964

Start Date

September 1 2025

End Date

May 1 2030

Last Update

September 15 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Fraser Orthopaedic Institute

New Westminster, British Columbia, Canada

2

London Health Sciences Centre

London, Ontario, Canada, N6A 5A5